QuidelOrtho Corporation (NASDAQ: QDEL) Stock Competitors & Peer Comparison
See QDEL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for QDEL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| QDEL | $13.97 | +0.29% | 952.6M | 10.43 | $1.34 | N/A |
| ALC | $70.50 | -2.19% | 34.4B | 22.17 | $3.18 | +0.51% |
| STE | $224.59 | -0.99% | 21.9B | 21.56 | $10.42 | +1.15% |
| MLAB | $127.78 | -0.58% | 715M | 12.89 | $9.91 | +0.50% |
| BWAY | $14.15 | -2.48% | 555M | 35.95 | $0.39 | N/A |
| SI | $20.32 | -0.34% | 421.4M | -10.61 | -$1.91 | N/A |
| MASS | $10.05 | +0.10% | 412.3M | -16.75 | -$0.60 | N/A |
| MOBI | $11.63 | +0.00% | 386.7M | -0.62 | -$18.78 | N/A |
| ANIK | $20.81 | -0.90% | 278.5M | 42.47 | $0.49 | N/A |
| LAB | $0.69 | +1.72% | 268.3M | -9.79 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
QDEL vs ALC Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, ALC has a market cap of 34.4B. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while ALC trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas ALC's P/E ratio is 22.17. In terms of profitability, QDEL's ROE is -0.55%, compared to ALC's ROE of +0.03%. Regarding short-term risk, QDEL is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check ALC's competition here
STERIS plc (NYSE: STE)
QDEL vs STE Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, STE has a market cap of 21.9B. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while STE trades at $224.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas STE's P/E ratio is 21.56. In terms of profitability, QDEL's ROE is -0.55%, compared to STE's ROE of +0.11%. Regarding short-term risk, QDEL is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
QDEL vs MLAB Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, MLAB has a market cap of 715M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while MLAB trades at $127.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas MLAB's P/E ratio is 12.89. In terms of profitability, QDEL's ROE is -0.55%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, QDEL is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
QDEL vs BWAY Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, BWAY has a market cap of 555M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while BWAY trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas BWAY's P/E ratio is 35.95. In terms of profitability, QDEL's ROE is -0.55%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, QDEL is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check BWAY's competition here
Shoulder Innovations, Inc. (NYSE: SI)
QDEL vs SI Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, SI has a market cap of 421.4M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while SI trades at $20.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas SI's P/E ratio is -10.61. In terms of profitability, QDEL's ROE is -0.55%, compared to SI's ROE of -0.26%. Regarding short-term risk, QDEL is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check SI's competition here
908 Devices Inc. (NASDAQ: MASS)
QDEL vs MASS Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, MASS has a market cap of 412.3M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while MASS trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas MASS's P/E ratio is -16.75. In terms of profitability, QDEL's ROE is -0.55%, compared to MASS's ROE of -0.25%. Regarding short-term risk, QDEL is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MASS's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
QDEL vs MOBI Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, MOBI has a market cap of 386.7M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while MOBI trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas MOBI's P/E ratio is -0.62. In terms of profitability, QDEL's ROE is -0.55%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, QDEL is more volatile compared to MOBI. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MOBI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
QDEL vs ANIK Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, ANIK has a market cap of 278.5M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while ANIK trades at $20.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas ANIK's P/E ratio is 42.47. In terms of profitability, QDEL's ROE is -0.55%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, QDEL is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check ANIK's competition here
Standard BioTools Inc. (NASDAQ: LAB)
QDEL vs LAB Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, LAB has a market cap of 268.3M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while LAB trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas LAB's P/E ratio is -9.79. In terms of profitability, QDEL's ROE is -0.55%, compared to LAB's ROE of -0.18%. Regarding short-term risk, QDEL is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check LAB's competition here
Trinity Biotech plc (NASDAQ: TRIB)
QDEL vs TRIB Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, TRIB has a market cap of 190.6M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while TRIB trades at $9.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas TRIB's P/E ratio is -0.16. In terms of profitability, QDEL's ROE is -0.55%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, QDEL is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check TRIB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
QDEL vs EDAP Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas EDAP's P/E ratio is -5.80. In terms of profitability, QDEL's ROE is -0.55%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, QDEL is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
QDEL vs NYXH Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, NYXH has a market cap of 162.1M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while NYXH trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas NYXH's P/E ratio is -0.64. In terms of profitability, QDEL's ROE is -0.55%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, QDEL is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
QDEL vs APYX Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, APYX has a market cap of 128.4M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while APYX trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas APYX's P/E ratio is -15.25. In terms of profitability, QDEL's ROE is -0.55%, compared to APYX's ROE of -0.79%. Regarding short-term risk, QDEL is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
QDEL vs SKIN Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, SKIN has a market cap of 88.8M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while SKIN trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas SKIN's P/E ratio is -3.11. In terms of profitability, QDEL's ROE is -0.55%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, QDEL is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check SKIN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
QDEL vs DRIO Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, DRIO has a market cap of 52.9M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while DRIO trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas DRIO's P/E ratio is -1.24. In terms of profitability, QDEL's ROE is -0.55%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, QDEL is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check DRIO's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
QDEL vs MDAI Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, MDAI has a market cap of 50M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while MDAI trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas MDAI's P/E ratio is -3.49. In terms of profitability, QDEL's ROE is -0.55%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, QDEL is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check MDAI's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
QDEL vs BEAT Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, BEAT has a market cap of 23.7M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while BEAT trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas BEAT's P/E ratio is -0.84. In terms of profitability, QDEL's ROE is -0.55%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, QDEL is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check BEAT's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
QDEL vs BEATW Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, BEATW has a market cap of 8.4M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas BEATW's P/E ratio is -0.02. In terms of profitability, QDEL's ROE is -0.55%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, QDEL is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
QDEL vs WOK Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while WOK trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas WOK's P/E ratio is N/A. In terms of profitability, QDEL's ROE is -0.55%, compared to WOK's ROE of -0.19%. Regarding short-term risk, QDEL is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
QDEL vs QTEXW Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, QDEL's ROE is -0.55%, compared to QTEXW's ROE of N/A. Regarding short-term risk, QDEL is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check QTEXW's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
QDEL vs FEED Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, FEED has a market cap of 3.1M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while FEED trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas FEED's P/E ratio is -0.03. In terms of profitability, QDEL's ROE is -0.55%, compared to FEED's ROE of -0.60%. Regarding short-term risk, QDEL is more volatile compared to FEED. This indicates higher risk in terms of short-term price fluctuations for QDEL.Check FEED's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
QDEL vs ITOC Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, ITOC has a market cap of 2.8M. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while ITOC trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas ITOC's P/E ratio is -0.95. In terms of profitability, QDEL's ROE is -0.55%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, QDEL is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check ITOC's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
QDEL vs TIVC Comparison September 2026
QuidelOrtho Corporation (NASDAQ: QDEL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QDEL stands at 952.6M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, QDEL is priced at $13.97 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QDEL currently has a P/E ratio of 10.43, whereas TIVC's P/E ratio is -0.04. In terms of profitability, QDEL's ROE is -0.55%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, QDEL is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for QDEL.Check TIVC's competition here